CSIMarket
 
Elite Pharmaceuticals Inc   (ELTP)
Other Ticker:  
 
 
Price: $0.1440 $0.00 0.000%
Day's High: $0.145 Week Perf: 7.46 %
Day's Low: $ 0.14 30 Day Perf: -24.13 %
Volume (M): 479 52 Wk High: $ 0.21
Volume (M$): $ 69 52 Wk Avg: $0.09
Open: $0.15 52 Wk Low: $0.03



 Market Capitalization (Millions $) 148
 Shares Outstanding (Millions) 1,024
 Employees 67
 Revenues (TTM) (Millions $) 46
 Net Income (TTM) (Millions $) 16
 Cash Flow (TTM) (Millions $) -12
 Capital Exp. (TTM) (Millions $) 1

Elite Pharmaceuticals Inc
Elite Pharmaceuticals Inc. is a global pharmaceutical company that focuses on the development, manufacturing, and commercialization of generic and branded pharmaceutical products. The company has a strong presence in the US, Europe, and Asia, with the majority of its business coming from the United States. Elite Pharmaceuticals has been in operation since 1984 and is headquartered in Northvale, New Jersey.

One of the primary areas of focus for Elite Pharmaceuticals is controlled-release drug delivery systems. The company has developed a proprietary technology that allows for the controlled release of drugs over an extended period of time. This technology has been applied to a wide range of drugs, including opioids for pain management, ADHD medications, and other therapeutics.

Elite Pharmaceuticals manufactures its products through its wholly-owned subsidiary, Elite Laboratories Inc. The company has a state-of-the-art manufacturing facility in Northvale, New Jersey, which is approved by the US Food and Drug Administration (FDA) and has been audited by regulatory agencies in Europe and Asia.

In addition to its focus on controlled-release drug delivery systems, Elite Pharmaceuticals also has a pipeline of new products in development. The company collaborates with other pharmaceutical companies and research institutions to develop new therapeutics for a variety of indications.

Elite Pharmaceuticals has a strong track record of commercial success. The company has a portfolio of more than 20 products under various stages of development and has successfully launched several products in the US market. Elite Pharmaceuticals has also received numerous accolades and awards for its innovative drug delivery systems and manufacturing capabilities.

The company's leadership team is led by CEO and President, Nasrat Hakim, who has over 30 years of experience in the pharmaceutical industry. The company also has a team of experienced executives, scientists, and engineers who are dedicated to advancing Elite Pharmaceuticals' mission of improving human health through innovative drug delivery systems.


   Company Address: 165 LUDLOW AVENUE NORTHVALE 7647 NJ
   Company Phone Number: 750-2646   Stock Exchange / Ticker: ELTP
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Elite Pharmaceuticals Inc

Improved headline: Elite Pharmaceuticals Inc's Strong Revenue Growth Fails to Offset Decline in Net Income



Elite Pharmaceuticals Inc, a leading pharmaceutical company, recently released its financial results for the third quarter of 2024, showcasing a mixed performance. While the company achieved balanced books with a per-share value of $0.00, it faced a decline in net income compared to the same period last year. Analysts attribute the decline to the absence of an income tax benefit.
One positive aspect of the report was the substantial growth in revenue. Elite Pharmaceuticals Inc recorded a strong 68.637% increase, reaching $15.04 million in the third quarter, up from $8.92 million a year ago. Sequentially, the company's revenue advanced by 11.854% from $13.45 million in the preceding reporting period.






 

Elite Pharmaceuticals Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com